FDA Authorizes Moderna and Johnson & Johnson Covid-19 Booster And Endorses Mix and Match StrategyBy Radiant Health
Published: October 24, 2021
Health News Briefs
The FDA authorized Moderna and Johnson & Johnson Covid-19 booster shots. The agency also gave its stamp of approval for the “mix and match” strategy which allows people to boost with a different Covid-19 vaccine than initially received. Those eligible for Moderna booster, administered at least six months after the second dose, include older adults over 65 years as well as younger adults at high risk due to medical conditions or work exposure. All (18 and older) who previously received the J & J vaccine are eligible for booster shots at least two months after their first dose.
Like what you're reading? Sign up for our free newsletter and never miss a post! Plus get a FREE digital version of our Issue No.10 with sign up.
- Pfizer’s Antiviral Pill is Very Effective - May 15, 2022
- Spain Considers Three Days Off for Menstrual Pain - May 15, 2022
- Moderna Requests Approval for its Children’s Vaccine - May 15, 2022
- Routine Colonoscopies Should Start at Age 45 - May 15, 2022
- Anti-inflammatory Drugs May Do More Harm Than Good - May 15, 2022
- Some People Die from a Happy Heart - May 8, 2022
- Johnson & Johnson Vaccine Can Cause Serious Blood Clots - May 8, 2022
- Omicron Variants Spreading Quickly - May 8, 2022
- Roe V. Wade Will Likely Be Overturned - May 8, 2022
- Menthol Cigarette Ban Will Benefit the Black Community - April 30, 2022